91 related articles for article (PubMed ID: 18727012)
1. Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study.
Zagana P; Haikou M; Giannopoulou E; Ioannou PV; Antimisiaris SG
Mol Nutr Food Res; 2009 May; 53(5):592-9. PubMed ID: 18727012
[TBL] [Abstract][Full Text] [Related]
2. Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition.
Zagana P; Klepetsanis P; Ioannou PV; Loiseau PM; Antimisiaris SG
Biomed Pharmacother; 2007 Sep; 61(8):499-504. PubMed ID: 17606357
[TBL] [Abstract][Full Text] [Related]
3. The effect of pH on the electrophoretic behaviour of a new class of liposomes: arsonoliposomes.
Fatouros DG; Klepetsanis P; Ioannou PV; Antimisiaris SG
Int J Pharm; 2005 Jan; 288(1):151-6. PubMed ID: 15607267
[TBL] [Abstract][Full Text] [Related]
4. In vivo distribution of arsonoliposomes: effect of vesicle lipid composition.
Zagana P; Haikou M; Klepetsanis P; Giannopoulou E; Ioannou PV; Antimisiaris SG
Int J Pharm; 2008 Jan; 347(1-2):86-92. PubMed ID: 17689900
[TBL] [Abstract][Full Text] [Related]
5. Stability and aggregation studies of non-sonicated arsonolipid-containing vesicles.
Fatouros DG; Bouropoulos N; Ioannou PV; Antimisiaris SG
Cell Mol Biol Lett; 2005; 10(1):173-83. PubMed ID: 15809688
[TBL] [Abstract][Full Text] [Related]
6. Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.
Gortzi O; Antimisiaris SG; Klepetsanis P; Papadimitriou E; Ioannou PV
Eur J Pharm Sci; 2003 Feb; 18(2):175-83. PubMed ID: 12594011
[TBL] [Abstract][Full Text] [Related]
7. Arsonoliposomes: effect of lipid composition on their stability and morphology.
Piperoudi S; Ioannou PV; Frederik P; Antimisiaris SG
J Liposome Res; 2005; 15(3-4):187-97. PubMed ID: 16393910
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.
Piperoudi S; Fatouros D; Ioannou PV; Frederik P; Antimisiaris SG
Chem Phys Lipids; 2006 Feb; 139(2):96-106. PubMed ID: 16405880
[TBL] [Abstract][Full Text] [Related]
9. Arsonoliposomes: preparation and physicochemical characterization.
Antimisiaris SG; Ioannou PV
Methods Mol Biol; 2010; 605():147-62. PubMed ID: 20072879
[TBL] [Abstract][Full Text] [Related]
10. In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice.
Antimisiaris SG; Klepetsanis P; Zachariou V; Giannopoulou E; Ioannou PV
Int J Pharm; 2005 Jan; 289(1-2):151-8. PubMed ID: 15652207
[TBL] [Abstract][Full Text] [Related]
11. Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.
Gortzi O; Papadimitriou E; Kontoyannis CG; Antimisiaris SG; Ioannou PV
Pharm Res; 2002 Jan; 19(1):79-86. PubMed ID: 11837704
[TBL] [Abstract][Full Text] [Related]
12. In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice.
Antimisiaris SG; Ioannou PV; Loiseau PM
J Pharm Pharmacol; 2003 May; 55(5):647-52. PubMed ID: 12831507
[TBL] [Abstract][Full Text] [Related]
13. Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione.
Haikou MN; Zagana P; Ioannou PV; Antimisiaris SG
J Nanosci Nanotechnol; 2006; 6(9-10):2974-8. PubMed ID: 17048506
[TBL] [Abstract][Full Text] [Related]
14. Physical stability of sonicated arsonoliposomes: effect of calcium ions.
Fatouros DG; Piperoudi S; Gortzi O; Ioannou PV; Frederik P; Antimisiaris SG
J Pharm Sci; 2005 Jan; 94(1):46-55. PubMed ID: 15761929
[TBL] [Abstract][Full Text] [Related]
15. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
16. Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery.
Fatouros DG; Ioannou PV; Antimisiaris SG
J Nanosci Nanotechnol; 2006; 6(9-10):2618-37. PubMed ID: 17048471
[TBL] [Abstract][Full Text] [Related]
17. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
18. Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation.
Mourtas S; Michanetzis GP; Missirlis YF; Antimisiaris SG
J Biomed Nanotechnol; 2009 Aug; 5(4):409-15. PubMed ID: 20055087
[TBL] [Abstract][Full Text] [Related]
19. Thermal behavior of novel non-sonicated arsonolipid-containing liposomes.
Koutsopoulos S; Fatouros DG; Ioannou PV; Antimisiaris SG
Biophys Chem; 2006 May; 121(2):150-4. PubMed ID: 16472907
[TBL] [Abstract][Full Text] [Related]
20. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells.
Zhang X; Gao F; Yu LL; Peng Y; Liu HH; Liu JY; Yin M; Ni J
Acta Pharmacol Sin; 2008 Aug; 29(8):942-50. PubMed ID: 18664327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
